Symptoms were associated with HRQOL impairments in patients recently diagnosed with colorectal or lung cancer. Additional supportive care implemented early in cancer care, regardless of cancer stage, may provide symptom relief and improve HRQOL.
The aim of this study was to assess reproducibility of the four-category Breast Imaging Reporting and Data System [BI-RADS] density measure and examine its relationship with a continuous measure of percent density.
Multidisciplinary tumor board meetings are common in cancer care, but limited evidence is available about their benefits. We assessed the associations of tumor board participation and structure with care delivery and patient outcomes.
This report shares research and analyses of claims data related to the design of a payment model for specialty oncology services for possible testing by the Center for Medicare and Medicaid Innovation at the Centers for Medicare & Medicaid Services.
The purpose of this study was to identify and analyze recently published cases of breast implant-associated anaplastic large cell lymphoma (ALCL), with an emphasis on diagnosis, staging, treatment, and outcomes.
The authors conducted a second structured expert consultation process to rate statements related to the diagnosis, management, and surveillance of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
Breast implant-associated anaplastic large cell lymphoma is a rare, nonaggressive cancer that can be treated by removal of the implant and surrounding capsule. Research is needed to identify risk factors; a patient registry would aid this process.
Most medical research focuses on fighting individual disease. But delayed aging could boost life expectancy by more than two years and yield more than $7 trillion over 50 years. Greater investment in research to delay aging could be a very efficient way to prevent disease, improve public health, and extend healthy life.